GERD is super common… Upwards of 25% of adults in western culture have GERD and climbing… obviously…
GERD can lead to cancer. Esophageal cancer is among the deadliest, with 5 year survival rates below of less than 20%.
PavMed received breakthrough designation for its EsoGuard/EsoCheck system to test for GERD/Eso Cancer, this device is the only one on the market with any real accuracy (sponge device is trash, less than 80% accuracy, breaks off, scrapes entire esophagus…)
They just started being reimbursed @ a blended rate of ~$2k per test on Jan 1 '21
So, lets do a little math….
PAVM has a current market cap of $160M
The US has a population of 332M
If 25% have or are susceptible to GERD….. we'll call it ~80M
If just ONE PERCENT of this at risk segment of the US gets tested we're talking about $160B in revenue… at ~80% profit
We're talking 10x current market cap… with just 1% getting tested… In just the US…
Oh and $PAVM also has 8 other devices in various stages of development… CarpX approved last year, carpal tunnel procedure can now be done by a tech…. No more surgery, healing time 1-2 weeks, not 3 months…
One of the devices they're working on is a LASER glucose monitor… This would turn PAVM into a global player in the medical device field overnight with one PR….
They also hired Stanley Lapidus of Exact Sciences ($EXAS) who commercialized poop in a box.
TLDR; This company is a hidden gem about to explode straight to the moon.
TL;TLDR; BUY $PAVM
Leave a Reply